Rheumatoid Arthritis Patient With Neurofibromatosis Type 1: Case Report and Review of the Literature

Yan-Jun Li; Shu-Jie Li; Dong-Mei Li; Hong-Xia Yan; Dong-Mei Shi

doi:10.7759/cureus.51986

journal article Jan 09, 2024

Rheumatoid Arthritis Patient With Neurofibromatosis Type 1: Case Report and Review of the Literature

Yan-Jun Li Shu-Jie Li Dong-Mei Li Hong-Xia Yan Dong-Mei Shi

Cureus · Springer Science and Business Media LLC

View at Publisher Save 10.7759/cureus.51986

Topics

No keywords indexed for this article. Browse by subject →

References

19

[1]

Cimino PJ, Gutmann DH. Neurofibromatosis type 1. Handb Clin Neurol. 2018, 148:799-811. 10.1016/B978-0-444-64076-5.00051-X 10.1016/b978-0-444-64076-5.00051-x

[2]

Fan J. Familial neurofibroma complicated with rheumatoid arthritis and autoimmune hemolytic anemia: three cases report. Chin J Hematol. 1996, 17:9.

[3]

Drago F, Pastorino C, Cecchi F, Parodi A. Segmental eruptive neurofibromatosis infliximab-induced. J Eur Acad Dermatol Venereol. 2016, 30:356-7. 10.1111/jdv.12770 10.1111/jdv.12770

[4]

Rischin A, De Silva T, Le Marshall K. Reversible eruption of neurofibromatosis associated with tofacitinib therapy for rheumatoid arthritis. Rheumatology (Oxford). 2019, 58:1111-3. 10.1093/rheumatology/kez012 10.1093/rheumatology/kez012

[5]

Nanda A. Autoimmune diseases associated with neurofibromatosis type 1. Pediatr Dermatol. 2008, 25:392-3. 10.1111/j.1525-1470.2008.00692.x 10.1111/j.1525-1470.2008.00692.x

[6]

Viskochil D, Buchberg AM, Xu G, et al.. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell. 1990, 62:187-92. 10.1016/0092-8674(90)90252-a 10.1016/0092-8674(90)90252-a

[7]

Mueller AL, Payandeh Z, Mohammadkhani N, et al.. Recent advances in understanding the pathogenesis of rheumatoid arthritis: new treatment strategies. Cells. 2021, 10:10.3390/cells10113017 10.3390/cells10113017

[8]

Fischer V, Haffner-Luntzer M. Interaction between bone and immune cells: Implications for postmenopausal osteoporosis. Semin Cell Dev Biol. 2022, 123:14-21. 10.1016/j.semcdb.2021.05.014 10.1016/j.semcdb.2021.05.014

[9]

Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest. 2000, 106:1481-8. 10.1172/JCI11176 10.1172/jci11176

[10]

Meng J, Zhao Y, Zhang L, Wang T, Chen L. Expression of 25-hydroxyvitamin D and interleukin-6 in peripheral blood of patients with rheumatoid arthritis. Chin J Clin Res. 2022, 35:190-3. 10.13429/j.cnki.cjcr.2022.02.009 10.13429/j.cnki.cjcr.2022.02.009

[11]

Lammert M, Friedman JM, Roth HJ, et al.. Vitamin D deficiency associated with number of neurofibromas in neurofibromatosis 1. J Med Genet. 2006, 43:810-3. 10.1136/jmg.2006.041095 10.1136/jmg.2006.041095

[12]

Tucker T, Schnabel C, Hartmann M, et al.. Bone health and fracture rate in individuals with neurofibromatosis 1 (NF1). J Med Genet. 2009, 46:259-65. 10.1136/jmg.2008.061895 10.1136/jmg.2008.061895

[13]

Konig MF, Sathiyakumar V, Phan CM, Schulman SP, Gelber AC. Inside and out. N Engl J Med. 2021, 384:1753-60. 10.1056/NEJMcps2034360 10.1056/nejmcps2034360

[14]

Nguyen R, Mir TS, Kluwe L, et al.. Cardiac characterization of 16 patients with large NF1 gene deletions. Clin Genet. 2013, 84:344-9. 10.1111/cge.12072 10.1111/cge.12072

[15]

Liao KP. Cardiovascular disease in patients with rheumatoid arthritis. Trends Cardiovasc Med. 2017, 27:136-40. 10.1016/j.tcm.2016.07.006 10.1016/j.tcm.2016.07.006

[16]

Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2012, 71:1524-9. 10.1136/annrheumdis-2011-200726 10.1136/annrheumdis-2011-200726

[17]

Aviña-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 2008, 59:1690-7. 10.1002/art.24092 10.1002/art.24092

[18]

Sattar N, McInnes IB. Vascular comorbidity in rheumatoid arthritis: potential mechanisms and solutions. Curr Opin Rheumatol. 2005, 17:286-92. 10.1097/01.bor.0000158150.57154.f9 10.1097/01.bor.0000158150.57154.f9

[19]

Weyand CM, Goronzy JJ, Liuzzo G, Kopecky SL, Holmes DR Jr, Frye RL. T-cell immunity in acute coronary syndromes. Mayo Clin Proc. 2001, 76:1011-20. 10.4065/76.10.1011 10.4065/76.10.1011

Metrics

0

Citations

19

References

Details

Published: Jan 09, 2024

Authors

Cite This Article

Yan-Jun Li, Shu-Jie Li, Dong-Mei Li, et al. (2024). Rheumatoid Arthritis Patient With Neurofibromatosis Type 1: Case Report and Review of the Literature. Cureus. https://doi.org/10.7759/cureus.51986

Rheumatoid Arthritis Patient With Neurofibromatosis Type 1: Case Report and Review of the Literature

You May Also Like